MARKET

BMRA

BMRA

Biomerica
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.710
-0.050
-1.81%
Opening 09:52 02/24 EST
OPEN
2.710
PREV CLOSE
2.760
HIGH
2.710
LOW
2.710
VOLUME
400
TURNOVER
--
52 WEEK HIGH
3.690
52 WEEK LOW
2.150
MARKET CAP
26.80M
P/E (TTM)
-10.5653
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BMRA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average BMRA stock price target is 6.25 with a high estimate of 6.25 and a low estimate of 6.25.

EPS

BMRA News

More
  • BMRA: Fiscal 2020 1H Sales Flat as Potentially Potent Growth Catalysts Emerge
  • Zacks Small Cap Research · 02/13 10:15
  • Biomerica Q2 EPS $(0.05), Sales $1.6M
  • Benzinga · 01/15 13:21
  • Biomerica Announces Second Quarter Financial Results; Sales Up 6.4% for the Quarter
  • GlobeNewswire · 01/15 13:19
  • We're Not Very Worried About Biomerica's (NASDAQ:BMRA) Cash Burn Rate
  • Simply Wall St. · 01/09 10:45

Industry

Medical Equipment, Supplies & Distribution
-2.32%
Healthcare Equipment & Supplies
-2.80%

Hot Stocks

Symbol
Price
%Change
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%
  • --
  • 0.00%

About BMRA

Biomerica, Inc. is a biomedical company, which develops, manufactures and markets medical diagnostic products for the early detection and monitoring of chronic diseases and medical conditions. The Company's medical diagnostic products are sold around the world in over two markets, including clinical laboratories and point of care (physicians' offices and over-the-counter drugstores). The Company operates in Europe, the United States, Asia, South America, the Middle East and other foreign countries. The Company's diagnostic test kits are used to analyze blood, urine or fecal specimens from patients in the diagnosis of various diseases and other medical complications, or to measure the level of specific hormones, antibodies, antigens or other substances, which exist in the human body in various concentrations. The Company primarily focuses on products for gastrointestinal (GI), food intolerances, diabetes and esoteric tests. The Company's diagnostic products use immunoassay technology.
More

Webull offers kinds of Biomerica, Inc. stock information, including NASDAQ:BMRA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BMRA stock news, and many more online research tools to help you make informed decisions.